
English
-
-
Controlling Dengue: Immunization Is a Pillar of Prevention
Medscape33 minutes -
Emerging Issues in Dengue Control
Takeda -
Dengue Prevention: Vaccination as Part of A Comprehensive Strategy for Disease Control
Takeda -
Dengue Vaccines
Takeda -
Insecticide resistance in dengue vectors from hotspots in Selangor, Malaysia
Takeda2 minutes -
Similarities and differences between 'cytokine storms’ in acute dengue and COVID-19
Takeda2 minutes -
Dengue: Not Just 1 Virus, Not Just 1 Infection
Medscape15 minutes -
Impact of SARS-CoV-2 interventions on dengue transmission
Takeda2 minutes -
Dengue Vectors
Takeda5 minutes -
Vector control
Takeda4 minutes -
Antibody Levels over Time
Takeda2 minutes -
Immune response to dengue virus
Takeda4 minutes -
Dengue virus and pathobiology
Takeda1 minutes -
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
ADVA92 minutes -
Dengue: Strategies to Limit Human Exposure to Disease-Carrying Mosquitos
Medscape33 minutes -
Mosquito-Borne Viral Diseases: Advice for Travelers to Endemic Areas
Medscape35 minutes -
NS1 and its potential association with severe dengue
Takeda3 minutes -
Dengue - unanswered scientific questions
Takeda11 minutes -
Wanderlust meets dengue: what you need to consider as HCP?
Takeda10 minutes -
Prevention of dengue
Takeda6 minutes -
Pandemic-associated mobility restrictions could cause increases in dengue virus transmission
Takeda2 minutes -
Professor Adi Utarini – Eliminating Dengue
35 minutes -
Dengue serotypes
Takeda4 minutes -
Combination of inflammatory and vascular markers in the febrile phase of dengue is associated with more severe outcomes
Takeda2 minutes -
A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection
Takeda2 minutes -
Coagulation abnormalities in Dengue fever infection: A systematic review and meta-analysis
Takeda2 minutes -
Field and classroom initiatives for portable sequence-based monitoring of dengue virus in Brazil
Takeda2 minutes -
Dengue in Latam - Understand Disease Control and the Value of Vaccination
Takeda8 minutes -
Dengue in APAC - Understand Disease Control and the Value of Vaccination
Takeda13 minutes -
The COVID-19 pandemic should not jeopardize dengue control
Takeda2 minutes -
Distinct Dengue Epidemiology and Viral Characteristics in Indonesia
ADVA25 minutes -
Hydrometeorological Hazards and Dengue Outbreak Prediction
ADVA19 minutes -
Mosquito Life Cycle
HHMI BioInteractive3 minutes -
Dengue Virus Life Cycle
HHMI BioInteractive4 minutes -
Dengue Prevention: Translating Knowledge into Action
Takeda
Dengue Academy is intended for an international audience of healthcare professionals outside of the US and UK.
This website has been initiated and developed by Takeda
© Copyright 2025 Takeda Pharmaceutical Company Limited. All rights reserved.
Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
VV-MEDMAT-55340, Date of preparation: November 2023